Generic-Drug Co. Concedes Infringement In Pfizer Heart Med Row
An Israeli drugmaker trying to market a generic version of one of Pfizer's historically more expensive brands of heart medication has agreed to limit its legal fight with the U.S. pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article